ATE311364T1 - Kristalline form 3 des natriumsalzes von 5-chlor- 2-methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid - Google Patents

Kristalline form 3 des natriumsalzes von 5-chlor- 2-methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid

Info

Publication number: ATE311364T1
Authority: AT; Austria
Prior art keywords: methoxy; bnzamid; methylaminothiocarbonylaminosulfonylphenyl; ethy; chlorine
Prior art date: 1999-04-16

Application number

AT00926805T

Other languages

English (en)

Inventor

Heinrich Christian Englert

Uwe Gerlach

Tobias Metzenthin

Harald Schneider

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-16

Filing date

2000-04-04

Publication date

2005-12-15

2000-04-04 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2005-12-15 Application granted granted Critical

2005-12-15 Publication of ATE311364T1 publication Critical patent/ATE311364T1/de

Links

NOJNFULGOQGBKB-UHFFFAOYSA-M sodium;3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoate Chemical compound [Na+].C1=NC(OCC)=CC=C1C(C=C1)=CC=C1CN1C2=CC=C(OCC=3N=CC(C)=CC=3)C=C2C(SC(C)(C)C)=C1CC(C)(C)C([O-])=O NOJNFULGOQGBKB-UHFFFAOYSA-M 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
- C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Surgery (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT00926805T 1999-04-16 2000-04-04 Kristalline form 3 des natriumsalzes von 5-chlor- 2-methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid ATE311364T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19917233A DE19917233A1 (de)	1999-04-16	1999-04-16	Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids
PCT/EP2000/002984 WO2000063167A1 (en)	1999-04-16	2000-04-04	Crystalline forms of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide

Publications (1)

Publication Number	Publication Date
ATE311364T1 true ATE311364T1 (de)	2005-12-15

Family

ID=7904803

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT00926805T ATE311364T1 (de)	1999-04-16	2000-04-04	Kristalline form 3 des natriumsalzes von 5-chlor- 2-methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid
AT05024254T ATE414059T1 (de)	1999-04-16	2000-04-04	Kristalline form des natriumsalzes von 5-chlor-2- methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT05024254T ATE414059T1 (de)	1999-04-16	2000-04-04	Kristalline form des natriumsalzes von 5-chlor-2- methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid

Country Status (33)

Country	Link
US (1)	US6723751B1 (de)
EP (2)	EP1173418B1 (de)
JP (1)	JP4662640B2 (de)
KR (1)	KR100700302B1 (de)
CN (1)	CN1168712C (de)
AR (1)	AR023479A1 (de)
AT (2)	ATE311364T1 (de)
AU (1)	AU773246B2 (de)
BR (1)	BR0010658A (de)
CA (1)	CA2370388C (de)
CZ (1)	CZ302459B6 (de)
DE (3)	DE19917233A1 (de)
DK (1)	DK1173418T3 (de)
EE (1)	EE04612B1 (de)
ES (1)	ES2251996T3 (de)
HK (1)	HK1046270B (de)
HR (1)	HRP20010744B1 (de)
HU (1)	HU229082B1 (de)
IL (2)	IL145921A0 (de)
ME (1)	MEP55708A (de)
MX (1)	MXPA01010275A (de)
MY (1)	MY122588A (de)
NO (1)	NO327798B1 (de)
NZ (1)	NZ514788A (de)
PL (1)	PL203809B1 (de)
RS (1)	RS50916B (de)
RU (1)	RU2235089C2 (de)
SI (1)	SI1173418T1 (de)
SK (1)	SK287175B6 (de)
TR (2)	TR200501142T2 (de)
TW (1)	TWI276622B (de)
WO (1)	WO2000063167A1 (de)
ZA (1)	ZA200108400B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20080008440A (ko) *	2003-03-17	2008-01-23	니뽄 다바코 산교 가부시키가이샤	Ｃｅｔｐ 억제제의 약제학적 조성물
TWI393560B (zh) *	2003-05-02	2013-04-21	Japan Tobacco Inc	包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE59401361D1 (de) *	1993-02-23	1997-02-06	Hoechst Ag	Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
DE19505397A1 (de) *	1995-02-17	1996-08-22	Hoechst Ag	Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
HK1040187B (zh) *	1998-09-10	2005-09-02	萨诺费－阿文蒂斯德国有限公司	苯磺酰(硫)脲與β-受體阻滯劑聯合在製備用於心臟迷走神經機能障礙治療和預防的藥物中的用途

1999
- 1999-04-16 DE DE19917233A patent/DE19917233A1/de not_active Withdrawn
2000
- 2000-04-04 AT AT00926805T patent/ATE311364T1/de active
- 2000-04-04 MX MXPA01010275A patent/MXPA01010275A/es active IP Right Grant
- 2000-04-04 RU RU2001130886/04A patent/RU2235089C2/ru not_active IP Right Cessation
- 2000-04-04 SI SI200030775T patent/SI1173418T1/sl unknown
- 2000-04-04 EP EP00926805A patent/EP1173418B1/de not_active Expired - Lifetime
- 2000-04-04 ES ES00926805T patent/ES2251996T3/es not_active Expired - Lifetime
- 2000-04-04 NZ NZ514788A patent/NZ514788A/xx not_active IP Right Cessation
- 2000-04-04 CZ CZ20013672A patent/CZ302459B6/cs not_active IP Right Cessation
- 2000-04-04 HR HR20010744A patent/HRP20010744B1/xx not_active IP Right Cessation
- 2000-04-04 TR TR2005/01142T patent/TR200501142T2/xx unknown
- 2000-04-04 HK HK02107874.4A patent/HK1046270B/zh not_active IP Right Cessation
- 2000-04-04 CA CA002370388A patent/CA2370388C/en not_active Expired - Fee Related
- 2000-04-04 WO PCT/EP2000/002984 patent/WO2000063167A1/en not_active Ceased
- 2000-04-04 PL PL351245A patent/PL203809B1/pl unknown
- 2000-04-04 DE DE60040811T patent/DE60040811D1/de not_active Expired - Lifetime
- 2000-04-04 SK SK1458-2001A patent/SK287175B6/sk not_active IP Right Cessation
- 2000-04-04 DK DK00926805T patent/DK1173418T3/da active
- 2000-04-04 ME MEP-557/08A patent/MEP55708A/xx unknown
- 2000-04-04 AU AU45428/00A patent/AU773246B2/en not_active Ceased
- 2000-04-04 BR BR0010658-5A patent/BR0010658A/pt not_active IP Right Cessation
- 2000-04-04 CN CNB008063184A patent/CN1168712C/zh not_active Expired - Fee Related
- 2000-04-04 DE DE60024431T patent/DE60024431T2/de not_active Expired - Lifetime
- 2000-04-04 AT AT05024254T patent/ATE414059T1/de not_active IP Right Cessation
- 2000-04-04 RS YUP-720/01A patent/RS50916B/sr unknown
- 2000-04-04 KR KR1020017013220A patent/KR100700302B1/ko not_active Expired - Fee Related
- 2000-04-04 TR TR2001/02993T patent/TR200102993T2/xx unknown
- 2000-04-04 HU HU0200791A patent/HU229082B1/hu not_active IP Right Cessation
- 2000-04-04 JP JP2000612263A patent/JP4662640B2/ja not_active Expired - Fee Related
- 2000-04-04 EP EP05024254A patent/EP1637519B1/de not_active Expired - Lifetime
- 2000-04-04 IL IL14592100A patent/IL145921A0/xx active IP Right Grant
- 2000-04-04 EE EEP200100532A patent/EE04612B1/xx not_active IP Right Cessation
- 2000-04-13 AR ARP000101712A patent/AR023479A1/es not_active Application Discontinuation
- 2000-04-14 US US09/549,538 patent/US6723751B1/en not_active Expired - Lifetime
- 2000-04-14 MY MYPI20001609A patent/MY122588A/en unknown
- 2000-05-10 TW TW089106840A patent/TWI276622B/zh not_active IP Right Cessation
2001
- 2001-10-12 ZA ZA200108400A patent/ZA200108400B/xx unknown
- 2001-10-14 IL IL145921A patent/IL145921A/en not_active IP Right Cessation
- 2001-10-15 NO NO20015014A patent/NO327798B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU4542800A (en)	2000-11-02
TWI276622B (en)	2007-03-21
DK1173418T3 (da)	2006-04-10
NO20015014L (no)	2001-10-15
PL351245A1 (en)	2003-04-07
NO327798B1 (no)	2009-09-28
CA2370388C (en)	2009-10-13
JP2002542230A (ja)	2002-12-10
HUP0200791A2 (hu)	2002-07-29
SK14582001A3 (sk)	2002-01-07
AU773246B2 (en)	2004-05-20
CN1168712C (zh)	2004-09-29
CN1354744A (zh)	2002-06-19
DE19917233A1 (de)	2000-10-19
HRP20010744A2 (en)	2003-04-30
ZA200108400B (en)	2003-04-30
NO20015014D0 (no)	2001-10-15
HU229082B1 (hu)	2013-07-29
MY122588A (en)	2006-04-29
MXPA01010275A (es)	2003-07-21
DE60024431T2 (de)	2006-07-27
EP1637519B1 (de)	2008-11-12
PL203809B1 (pl)	2009-11-30
DE60024431D1 (en)	2006-01-05
ES2251996T3 (es)	2006-05-16
AR023479A1 (es)	2002-09-04
BR0010658A (pt)	2002-02-19
CA2370388A1 (en)	2000-10-26
EP1637519A1 (de)	2006-03-22
KR100700302B1 (ko)	2007-03-29
TR200501142T2 (tr)	2005-08-22
EP1173418A1 (de)	2002-01-23
IL145921A0 (en)	2002-07-25
TR200102993T2 (tr)	2002-03-21
KR20010109355A (ko)	2001-12-08
RU2235089C2 (ru)	2004-08-27
HK1046270A1 (en)	2003-01-03
JP4662640B2 (ja)	2011-03-30
SK287175B6 (sk)	2010-02-08
EE200100532A (et)	2002-12-16
HRP20010744B1 (hr)	2010-08-31
SI1173418T1 (sl)	2006-02-28
HUP0200791A3 (en)	2005-04-28
RS50916B (sr)	2010-08-31
YU72001A (sh)	2004-07-15
IL145921A (en)	2006-07-05
EE04612B1 (et)	2006-04-17
CZ302459B6 (cs)	2011-06-01
DE60040811D1 (de)	2008-12-24
EP1173418B1 (de)	2005-11-30
MEP55708A (en)	2011-05-10
NZ514788A (en)	2003-03-28
CZ20013672A3 (cs)	2002-01-16
HK1046270B (zh)	2005-03-11
WO2000063167A1 (en)	2000-10-26
US6723751B1 (en)	2004-04-20
ATE414059T1 (de)	2008-11-15

Legal Events

Date

Code

Title

Description

2006-04-15

UEP

Publication of translation of european patent specification

Ref document number: 1173418

Country of ref document: EP

Publication	Publication Date	Title
DE69811892D1 (de)	2003-04-10	Kristalline form von omeprazol-natriumsalz
DE60004317D1 (de)	2003-09-11	Salze von Sulfonium-Verbindungen
ATE236899T1 (de)	2003-04-15	Neue kristallinische form des kaliumsalzes des (s)-omeprazols
EE200000031A (et)	2000-10-16	Uued spiroasabitsüklilised heterotsüklilised ühendid
NO20016319L (no)	2002-02-28	VLA-4 inhibitor-forbindelser
EE200300001A (et)	2004-08-16	Perindopriili tert-butüülamiinsoola kristallilinealfa-vorm
ATE257836T1 (de)	2004-01-15	Salz von naphthyridincarbonsäure-derivaten
DE69905054D1 (de)	2003-02-27	KRISTALLINE FORMEN VON EtO2C-CH2-(R)Cgl-Aze-Pab-OH
HUP0202536A3 (en)	2003-04-28	Crystals of the sodium salt of pravastatin
ID28483A (id)	2001-05-31	2-(3,5-bis-trifluorometil-fenil)-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il)-isobutiramida
NO20020030L (no)	2002-03-05	Krystallinske 1-metylkarbapenemforbindelser
ID23803A (id)	2000-05-11	Turunan-turunan 2-(4-aril atau heteroaril-piperazin-1-ilmetil)-1h-indola
DE60107074D1 (de)	2004-12-16	Kristallin form ii von cabergolin
NO20021525D0 (no)	2002-03-26	Polymorft salt
ATE339438T1 (de)	2006-10-15	Substanziell kristalline form von melagatran
ID27766A (id)	2001-04-26	Garam-garam paroksetin
EE200100381A (et)	2002-12-16	Morfolinobensamiidi uued soolad
EE200100017A (et)	2002-06-17	N-tert-butüülhüdroksüülamiini uued soolad
ATE414059T1 (de)	2008-11-15	Kristalline form des natriumsalzes von 5-chlor-2- methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid
PT1175417E (pt)	2004-04-30	Compostos substituidos de benzolactamas
DE69940563D1 (de)	2009-04-23	Wachstum von aluminium-einkristallen
DK1224179T3 (da)	2004-10-25	Natrium-hydrogen-udbytter type 1-inhibitorkrystaller
ID26940A (id)	2001-02-22	Garam fosfat isopropil-metil-[2-(3-n-propoksifenoksi)-etil] amina
ID25793A (id)	2000-11-02	Garam-garam paroksetin